Sign in

    Charles ReidTD Cowen

    Charles Reid is a Senior Equity Research Analyst at TD Cowen, focused on the financial technology sector with coverage of high-profile companies such as SoFi Technologies. He has delivered market-relevant investment recommendations—including a recent 'hold' rating on SoFi with a precise price target—supporting TD Cowen's reputation for analytical depth. Reid began his career in equity research and has steadily advanced to his current senior role, consistently providing actionable insights to institutional investors. He holds professional securities credentials recognized by FINRA and is known for thorough market analyses and credible research notes.

    Charles Reid's questions to DarioHealth Corp (DRIO) leadership

    Charles Reid's questions to DarioHealth Corp (DRIO) leadership • Q2 2025

    Question

    Charles Reid of TD Cowen inquired about the drivers of the Q2 sequential revenue decline, specifically asking if customer churn was a factor beyond the known health plan scope reduction and slower new client ramps. He also requested details on the discontinued services.

    Answer

    CEO Erez Raphael clarified that the revenue decline was not due to ARR churn, which maintains an 85% retention rate, but rather a non-recurring Q1 revenue item and the previously disclosed loss of a large health plan contract. CCO Steven Nelson added that the discontinued service was a Medicaid maternity program which the client chose to insource.

    Ask Fintool Equity Research AI